Myasthenia gravis: A population based epidemiological study in Cambridgeshire, England

Journal of Neurology Neurosurgery and Psychiatry

Volumn 65, Issue 4, 1998, Pages 492-496

  Robertson, N P ^a   Deans, J ^a   Compston, D A S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Incidence; Myasthenia gravis; Prevalence

Indexed keywords

ADULT; AGED; AGING; ARTICLE; AUTOIMMUNE DISEASE; DISEASE COURSE; DISEASE DURATION; EXTRAOCULAR MUSCLE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REMISSION; SEX RATIO; THYMECTOMY; THYMOMA; UNITED KINGDOM;

EID: 0031755518     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.65.4.492     Document Type: Article

References (18)

1. Phillips LH, Torner JC. Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology 1996;47:1233-8.
2. Cambridge County Council Research Group. Population forcasts 1989-2001. Cambridge: Cambridgeshire County Council, 1992.
3. Osserman KE, Genkins G. Studies in myasthenia grans: renew of a 20 year experience in over 1200 patients. Mt Sinai J Med 1971;38:497-536.
4. Okinaka S, Reese HH, Katsuki S, et al. The prevalence of multiple sclerosis and other neurological diseases in Japan. Acta Neurol Scand 1966;42:68-76.
5. Kyriallis K, Hristova AH, Middleton LT. What is the real epidemiology of myasthenia gravis [abstract]? Neurology 1995;-15:A351-2.
6. Robertson NP, Compston DAS. Surveying multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1995;58:2-6.
7. Ferguson FR, Hutchinson EC, Liversedge BA. Myasthenia gravis results of clinical management. Lancet 1955;ii: 636-9.
8. Garland H, Clark ANG. Myasthenia gravis: a personal study of 60 cases. BMJ 1956;i:1259-62.
9. Pennington GW, Wilson A. Incidence of myasthenia in the Merseyside conurbation. In: Viets HR, ed. Proceedings of the second international symposium. Springfield, IL: 1961:337-45.
10. Schon F, Drayson M, Thompson RA. Myasthenia gravis and elderly people. Age Aging 1996;25:56-8.
11. Storm-Mathisen A. Epidemiology of myasthenia in Norway. Acta Neurol Scand 1984;70:274-84.
12. Somnier FE, Keiding N, Paulson OB. Epidemiology of myasthenia gravis in Denmark. Arch Neurol 1991;48:733-9.
13. Giagheddu M, Puggioni G, Sanna G. Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-86). Acta Neurol Scand 1989;79:326-33.
14. Beekman R, Kuks JBM, Oosterhuis HJGH. Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol 1997;244:112-8.
15. Phillips LH, Torner JC, Anderson MS, et al. The epidemiology of myasthenia gravis in central and western Virginia. Neurology 1992;42:1888-93.
16. Oosterhuis HJGH. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry 1989;52:1121-7.
17. Ferrari G, Lovaste MG. Epidemiology of myasthenia gravis in the province of Trento (northern Italy). Neuroepidemiology 1992;11:135-42.
18. Yu YL, Hawkins BR, Ip MSM, et al. Myasthenia in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurol Scand 1992;86:113-9.